期刊文献+

趋化因子CCL20及CCL22在狼疮鼠浆膜腔液中的表达及意义 被引量:2

The expression of chemokines CCL20 and CCL22 in the serous membrane effusion of lupus mouse and its significance
下载PDF
导出
摘要 目的探讨趋化因子CCL20及CCL22在狼疮鼠浆膜腔液中的表达及意义。方法以9只B6.MRL-Faslpr/J狼疮小鼠为观察组,6只同系C57BL/6J小鼠为对照组。取2组小鼠胸膜及腹膜腔液,用ELISA方法检测其中CCL20及CCL22的表达水平,并与小鼠血清中ANA、dsDNA抗体的含量以及小鼠24 h尿蛋白含量进行关联性分析。结果 CCL20在狼疮鼠浆膜腔液中高表达,与对照组相比两者差异有统计学意义(P<0.05),而CCL22与对照组相比两者差异无统计学意义(P>0.05);狼疮小鼠浆膜腔液CCL20含量与血清ds-DNA和24 h尿蛋白量呈正相关(P<0.05),与血清中ANA无明显相关性(P>0.05);而狼疮小鼠浆膜腔液CCL22含量与血清ds-DNA、ANA及24 h尿蛋白量均无明显相关性(P>0.05)。结论趋化因子CCL20可能参与狼疮鼠浆膜腔病变的发生,与狼疮鼠的病情活动、肾损害有一定相关性。 To evaluate the expression and significance of CCL22 and CCL20 in the serous membrane effusion of lupus mouse, nine B6.MRL-Fas^lpr/J lupus mice were selected as experimental group and six C57BL/6J mice as healthy controls. CCL20 and CCL22 levels in serous membrane effusion were assessed by enzyme linked immunosorbent assay (ELISA) for analyze their correlation with serous ANA, serous ds-DNA antibody, and 24 h urine protein in lupus mice. ELISA showed CCL20 level of serous membrane effusion was significantly increased in lupus mouse compared with that in healthy controls (P〈 0.05), but CCL22 level did not show difference (P〉 0.05). The CCL20 of serous membrane effusion was positively correlated with serum ds-DNA antibody and the 24 h urine protein (P〈0.050), but not correlated with serum ANA (P〉 0.05). The CCL22 of serous membrane effusion was not correlated with serum ANA, serum ds-DNA, or 24 h urine protein. In conclusion, CCL20 may be involved in the oromeningitis of lupus mouse and may be correlated with the pathogenesis and disease activity of lupus mouse.
出处 《免疫学杂志》 CAS CSCD 北大核心 2013年第7期597-600,共4页 Immunological Journal
基金 广西自然科学基金(2010GXNSFA013186) 广西青年科学基金(桂科青0542055) 广西卫生厅重点课题(桂卫重200829)
关键词 系统性红斑狼疮 B6.MRL-Faslpr/J小鼠 趋化因子CCL20 趋化因子CCL22 Systemic lupus erythematosus B6.MRL-Fas^lpr/J mice Chemokine CCL22 Chemokine CCL22
  • 相关文献

参考文献13

  • 1Nose M, Nishihara M, Fujii H. Genetic basis of the complex pathological manifestations of collagen disease: lessons from MRL/lpr and related mouse models [J]. Int Rev Immunol, 2000, 19(4/5): 473-498. 被引量:1
  • 2Kulkarni O, Anders HJ. Chemokines in lupus nephritis[J]. Front Biosci, 2008, 13: 3312-3320. 被引量:1
  • 3Apostolidis SA, Crispin JC, Tsokos GC. IL-17-producing T cells in lupus nephritis[J]. Lupus, 2011, 20(2): 120-124. 被引量:1
  • 4彭学标,王媛,白璐.Th17细胞在系统性红斑狼疮免疫炎症反应中的作用机制研究[J].免疫学杂志,2012,28(3):237-240. 被引量:4
  • 5刘锐,谢其冰,刘怡欣,李昕怡,刘毅,刘钢.狼疮活跃度与临床表现和免疫血清学的关系[J].免疫学杂志,2010,26(9):793-798. 被引量:8
  • 6Varona R, Villares R, Carramolino L, et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses[J]. J Clin Invest, 2001, 107(6): R37-45. 被引量:1
  • 7Hase K, Tani K, Shimizu T, et al. Increased CCR4 expression in active systemic lupus erythematosus[J]. J Leukoc Biol. 2001.70(5): 749-755. 被引量:1
  • 8杨海琼,邓丹琪,金从国,张佩莲,周晓鸿.趋化因子CCL22/CCR4在SLE发病中的作用[J].中华皮肤科杂志,2008,41(11):726-728. 被引量:1
  • 9Kaneko H, Ogasawara H, Naito T, et al. Circulating levels of beta-chemokines in systemic lupus erythematosus[J]. J Rheumatol, 1999, 26(3): 568-573. 被引量:1
  • 10Narumi S, Takeuchi T, Kobayashi Y, et al. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus[J]. Cytokine, 2000, 12(10): 1561-1565. 被引量:1

二级参考文献38

  • 1刘海娜,吴春玲,蒋莉,张晓莉,李舒帆,王晓非.系统性红斑狼疮患者血浆巨噬细胞衍生趋化因子水平及临床意义[J].中华风湿病学杂志,2005,9(3):142-144. 被引量:8
  • 2Hase K, Tani K, Shimizu T, et al. Increased CCR4 expression in active systemic lupus erythematosus. J Leukoc Biol, 2001, 70 (5): 749-755. 被引量:1
  • 3Yang PT, Kasai H, Zhao LJ, et al. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol, 2004, 138(2): 342-347. 被引量:1
  • 4Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature, 1999, 400(6746): 776-780. 被引量:1
  • 5Lee SS, Li CS, Li PC. Clinical profile of Chinese patients with systemic lupus erythematosus [J]. Lupus, 1993, 2(2): 105-109. 被引量:1
  • 6Cross LS, Aslam A, Misbah SA. Antinuclear antibody-negative lupus as a distinct diagnostic entity--does it no longer exist? [J]. Qjm, 2004, 97(5):303-308. 被引量:1
  • 7Yee CS, Hussein H, Skan J,et al. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus [J]. Rheumatology (Oxford), 2003, 42(2):276-279. 被引量:1
  • 8Schur PH, Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus [J]. N Engl J Med, 1968, 278(10):533-538. 被引量:1
  • 9Esdaile JM, Abrahamowicz M, Joseph L, et al. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail [J]. Arthritis Rheum, 1996, 39(3):370-378. 被引量:1
  • 10Barr SG, Zonana-Nacach A, Magder LS, et al. Patterns of disease activity in systemic lupus erythematosus [J]. Arthritis Rheum, 1999, 42(12):2682-2688. 被引量:1

共引文献10

同被引文献21

  • 1王淇泓,周晔,胡志德,王爱华,邓燕,邓安梅,仲人前.TNFSF9在原发性胆汁性肝硬化的表达及其临床意义[J].临床军医杂志,2010,38(4):558-559. 被引量:1
  • 2Kobayashi Y, Aizawa A, Takizawa T, et al. DNA methylation changes between relapse and remission of minimal change nephrotic syndrome[J]. Pediatr Nephrol, 2012, 27(12):2233-2241. 被引量:1
  • 3Kaneko K, Tsuji S, Kimata T, et al. Pathogenesis of childhood idiopathic nephrotic syndrome:a paradigm shift from T-cells to podocytes[J]. World J Pediatr, 2015, 11(1):21-28. 被引量:1
  • 4Wan Y F, Huang Z H, Jing K, et al. Azithromycin attenuates pulmonary inflammation and emphysema in smoking-induced COPD model in rats[J]. Respir Care, 2015, 60(1):128-134. 被引量:1
  • 5Abootaleb S, Paul C. Challenges and future trends in DNA microarray analysis[J]. Compr Anal Chem, 2014, 63:25-46. 被引量:1
  • 6Petrovic-Djergovic D, Popovic M, Chittiprol S, et al. CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis[J]. Clin Exp Immunol, 2015, 180(2):305-315. 被引量:1
  • 7Fenwick P S, Macedo P, Kilty I C, et al. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells[J]. PLoS One, 2015, 10(6):e0128757. 被引量:1
  • 8Li D T, Ye Y Q, Deng L, et al. Gene expression profiling analysis of deoxynivalenol-induced inhibition of mouse thymic epithelial cell proliferation[J]. Environ Toxicol Pharmacol, 2013, 36(2):557-566. 被引量:1
  • 9Zhang J, Yanez D, Floege A, et al. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation[J]. J Renin Angiotensin Aldosterone Syst, 2015, 16(2):234-248. 被引量:1
  • 10Lin S J, Lee W J, Liang Y J, et al. Azithromycin inhibits IL-5 production of T helper type 2 cells from asthmatic children[J]. Int Arch Allergy Immunol, 2011, 156(2):179-186. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部